<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=ProgId content=OneNote.File>
<meta name=Generator content="Microsoft OneNote 15">
<link id=Main-File rel=Main-File href=d5b9d80542894bd78f7413552681baea.htm>
<link rel=File-List href="d5b9d80542894bd78f7413552681baea.files/filelist.xml">
</head>

<body lang=zh-TW style='font-family:Calibri;font-size:11.0pt'>

<div style='direction:ltr;border-width:100%'>

<div style='direction:ltr;margin-top:0in;margin-left:0in;width:6.5055in'>

<div style='direction:ltr;margin-top:0in;margin-left:0in;width:3.4388in'>

<p style='margin:0in;font-family:"Calibri Light";font-size:20.0pt' lang=en-US>Acute
coronary syndrome</p>

</div>

<div style='direction:ltr;margin-top:.0388in;margin-left:0in;width:2.7006in'>

<p style='margin:0in;font-family:Calibri;font-size:10.0pt;color:#666666'
lang=en-US>Wednesday, February 26, 2025</p>

<p style='margin:0in;font-family:Calibri;font-size:10.0pt;color:#666666'
lang=en-US>5:29 PM</p>

</div>

<div style='direction:ltr;margin-top:.4305in;margin-left:0in;width:6.5055in'>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style='font-family:"Microsoft JhengHei Light";font-size:16.0pt'>編輯格式</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
      style='font-family:"Microsoft JhengHei Light";font-size:16.0pt'>顏色註記方式</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt'
       lang=zh-TW>重要標題</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt' lang=en-US> : </span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#1E4E79' lang=zh-TW>母標題藍色</span><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt;
       color:#1E4E79' lang=en-US>(</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#1E4E79' lang=zh-TW>最暗</span><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt;
       color:#1E4E79' lang=en-US>)</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#1E4E79' lang=zh-TW>標記</span><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt'
       lang=en-US>/</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#2E75B5' lang=zh-TW>子標題藍色</span><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt;
       color:#2E75B5' lang=en-US>(</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#2E75B5' lang=zh-TW>較暗</span><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt;
       color:#2E75B5' lang=en-US>,25%)</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#2E75B5' lang=zh-TW>標記</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt'
       lang=zh-TW>重要術式治療藥物</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt' lang=en-US> : </span><span style='font-weight:bold;
       font-family:"Microsoft JhengHei Light";font-size:11.0pt;color:#70AD47'
       lang=zh-TW>綠色標記</span><span style='font-weight:bold;font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#70AD47' lang=en-US>+</span><span
       style='font-weight:bold;font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#70AD47' lang=zh-TW>粗體</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt'
       lang=zh-TW>重要內文</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt' lang=en-US> : </span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#C00000' lang=zh-TW>紅色</span><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt;
       color:#C00000' lang=en-US>(</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#C00000' lang=zh-TW>標準色彩</span><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt;
       color:#C00000' lang=en-US>)</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt' lang=en-US>/</span><span style='font-weight:bold;
       font-family:"Microsoft JhengHei Light";font-size:11.0pt;color:#ED7D31'
       lang=zh-TW>橘色</span><span style='font-weight:bold;font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#ED7D31' lang=en-US>+</span><span
       style='font-weight:bold;font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#ED7D31' lang=zh-TW>粗體</span><span
       style='font-weight:bold;font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#ED7D31' lang=en-US>(</span><span
       style='font-weight:bold;font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#ED7D31' lang=zh-TW>橘色那一欄第一個</span><span
       style='font-weight:bold;font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:#ED7D31' lang=en-US>)</span><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt'
       lang=en-US>(</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt' lang=zh-TW>如果同色太醜就紅橘相間</span><span style='font-family:
       "Microsoft JhengHei Light";font-size:11.0pt' lang=en-US>)</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt'
       lang=zh-TW>直接來複製顏色格式一定不會錯</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt' lang=en-US>xd</span></li>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei Light";
font-size:11.0pt' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style='font-family:"Microsoft JhengHei Light";font-size:16.0pt'>流行病學（Epidemiology）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
      lang=en-US><span style='font-family:"Microsoft JhengHei Light";
      font-size:14.0pt'>台灣急性冠狀症候群ACS 現況</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt'>ACS 是台灣主要的心血管疾病之一，發病率隨年齡增加</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt'>STEMI 與 NSTEMI 皆可導致心衰竭、心律不整、猝死</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt'>近年來，高齡、糖尿病、腎功能不全患者比例增加</span></li>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.0pt'
lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>急性冠症候群（Acute
     Coronary Syndromes, ACS）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt;color:black'>急性冠症候群主要由</span><span
      style='font-family:"Microsoft JhengHei";font-size:14.0pt;color:#2E75B5'>動脈粥樣硬化斑塊破裂</span><span
      style='font-family:"Microsoft JhengHei";font-size:14.0pt;color:black'>（Plaque
      Rupture），</span><span style='font-family:"Microsoft JhengHei";font-size:
      14.0pt;color:#2E75B5'>導致血栓形成（Thrombus Formation）引起</span><span
      style='font-family:"Microsoft JhengHei";font-size:14.0pt;color:black'>，依據血管阻塞程度可分為以下類型：</span></li>
 </ul>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt;color:#1E4E79'>ACS分類</span></li>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>類型</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:#C00000;text-align:center'>血管阻塞程度</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4138in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:#C00000;text-align:center'>ECG 變化</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:#C00000;text-align:center'>心肌酵素（Troponin）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:#C00000'>不穩定型心絞痛（Unstable Angina, UA）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>部分阻塞（不完全阻塞）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>可能有ST段壓低或T 波倒置</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>正常</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:#C00000'>非ST段抬高型心肌梗塞（NSTEMI）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>部分阻塞（不完全阻塞）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4145in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>ST段壓低或T波改變</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>上升</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:#C00000'>ST段抬高型心肌梗塞（STEMI）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>完全阻塞（100%）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4138in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>ST段抬高</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>上升</p>
  </td>
 </tr>
</table>

</div>

<p style='margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt;color:#1E4E79'>不穩定型心絞痛</span><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt;color:black'>（Unstable
     Angina, UA）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>機轉：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>斑塊破裂
       </span><span style='font-family:"Segoe UI Symbol";font-size:11.0pt;
       color:black'>➝ </span><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:#C00000'>部分血栓形成</span><span style='font-family:
       "Microsoft JhengHei";font-size:11.0pt;color:black'>（但未完全阻塞）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>心肌未壞死</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>（沒有心肌酵素上升）</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>臨床表現：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>休息時胸痛（新發或惡化）</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>，可能持續
       &gt;10分鐘，&lt; 30分鐘</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>與穩定型心絞痛（Stable
       Angina）不同，休息時仍可能發作</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>ECG
       可能正常或出現 ST 段壓低 / T 波倒置</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>診斷關鍵：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>無心肌酵素上升</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>（Troponin、CK-MB
       正常）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>ECG
       可能有 ST 段壓低 / T 波倒置，但 無 ST 段抬高</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'
       lang=en-US>GRACE/TIMI score 風險評估</span><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:black' lang=en-US>決定是否早期介入</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt' lang=zh-TW><br>
              </span>&nbsp;</li>
  </ul>
 </ul>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt;color:#1E4E79'>非ST段抬高型心肌梗塞</span><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt;color:black'>（NSTEMI）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'><span style='mso-spacerun:yes'> </span>機轉：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>部分血栓阻塞</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>（導致部分心肌缺血壞死）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>影響內膜層心肌（Subendocardial
       Infarction）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>心肌酵素上升</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>（Troponin↑）</span></li>
  </ul>
 </ul>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>臨床表現：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt;
       color:#C00000'>持續性胸痛 &gt; 10分鐘，&lt; 30分鐘</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>可能伴隨呼吸困難、盜汗、噁心</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>ECG可能有ST段壓低
       / T波倒置，但無ST段抬高</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>診斷關鍵：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>心肌酵素上升</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>（Troponin、CK-MB
       ↑）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>ECG：ST段壓低
       / T波倒置</span><span style='font-family:"Microsoft JhengHei";font-size:
       11.0pt;color:black'>（但無 ST段抬高）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>GRACE/TIMI
       score 風險評估</span><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:black'>決定是否早期介入</span></li>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt;color:black'><span style='font-family:"Microsoft JhengHei";
     font-size:16.0pt;color:#1E4E79'>TIMI Score</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>預測</span><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:#2E75B5'>14天內心血管事件（死亡、MI、需緊急血運重建）的風險</span><span
      style='font-family:"Microsoft JhengHei";font-size:14.0pt;color:black'>，滿分7分，分數越高，風險越高！</span></li>
 </ul>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.4791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>危險因子</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>評分（每項 +1 分）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.4791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>年齡 ≥ 65 歲</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>+1</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.4798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>≥ 3 個冠心病危險因子（高血壓、糖尿病、吸菸、高膽固醇、早發冠心病家族史）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>+1</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.4791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>已知冠狀動脈疾病（CAD，冠狀動脈狹窄 &gt; 50%）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>+1</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.4791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>過去 24 小時內出現嚴重心絞痛（Angina）≥ 2 次</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>+1</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.4791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>使用抗血小板藥物（Aspirin）但仍有症狀</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>+1</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.4791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>心電圖（ECG）表現 ST 段壓低 ≥ 0.5mm</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>+1</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:4.4791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>初始心肌酵素（Troponin 或 CK-MB）升高</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2291in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>+1</p>
  </td>
 </tr>
</table>

</div>

<p style='margin-top:5pt;margin-bottom:5pt;font-family:"Microsoft JhengHei";
font-size:16.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
     font-size:16.0pt;color:black'>TIMI Score 風險分層</span></li>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8888in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>TIMI 分數</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>14 天內心血管事件風險</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>0-1 分</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>低風險（4-5%）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>2 分</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>中低風險（8%）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>3 分</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>中等風險（13%）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>4 分</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>中高風險（20%）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>5-7 分</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高風險（26-41%）</p>
  </td>
 </tr>
</table>

</div>

<p style='margin-left:.375in;margin-top:5pt;margin-bottom:5pt;font-size:11.0pt;
color:#C00000' lang=en-US><span style='font-family:"Microsoft JhengHei"'>TIMI
Score </span><span style='font-family:"Cambria Math"'>≥</span><span
style='font-family:"Microsoft JhengHei"'> 3 → 建議做侵入性治療（PCI）</span></p>

<p style='margin-left:.375in;margin-top:5pt;margin-bottom:5pt;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt;color:black' lang=en-US><span style='font-family:"Microsoft JhengHei";
     font-size:16.0pt'>GRACE score</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt;color:black'>在NSTEMI及UA的風險評估上，GRACE
      Score 和 TIMI Score都可用於臨床決策，但台灣與國際guideline（TSOC、AHA、ESC）</span><span
      style='font-family:"Microsoft JhengHei";font-size:14.0pt;color:#C00000'>較推薦使用
      GRACE Score</span><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>來</span><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:#C00000'>評估預後風險與是否需要早期介入治療</span><span
      style='font-family:"Microsoft JhengHei";font-size:14.0pt;color:black'>。</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>主要用於評估急性冠症候群（ACS）患者的院內及出院後6個月內死亡風險，特別適用於NSTEMI與不穩定型心絞痛（UA）</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei Light";font-size:14.0pt;color:black'>GRACE
      Score根據以下8個臨床指標計算分數</span><span style='font-family:"Microsoft JhengHei Light";
      font-size:14.0pt;color:#1A1A1A'>，計分法複雜，可上網算：</span></li>
 </ul>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.7083in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black;text-align:center'>變項</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black;text-align:center'>內容</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>年齡</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>年齡越大，風險越高</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>心率（Heart rate）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>心率越高，風險越高</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>收縮壓（SBP, mmHg）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>血壓越低，風險越高</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>Killip 分級</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>依據心臟衰竭嚴重度評估</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>心搏停止（Cardiac arrest）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>是否有院外心搏停止</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>血清肌酐（Serum Creatinine, mg/dL）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>腎功能不佳者風險較高</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>ST 段變化（ST-segment deviation）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>ST 段改變者風險較高</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>心肌標誌物（Cardiac biomarkers）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>Troponin 或 CK-MB 陽性者風險較高</p>
  </td>
 </tr>
</table>

</div>

<ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt;color:black' lang=en-US><span style='font-family:"Microsoft JhengHei Light";
     font-size:14.0pt'>GRACE Score 依照總分預測院內及6個月內死亡風險，並用於決定是否進行侵入性治療。</span></li>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.7083in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black;text-align:center'>GRACE 總分</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black;text-align:center'>死亡風險</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black;text-align:center'>風險等級</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3826in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black;text-align:center'>建議處置</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>≤108</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>低風險</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>院內死亡率 &lt;1%</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.2513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>可考慮藥物保守治療</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>109–140</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>中風險</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>院內死亡率 1-3%</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.3826in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>建議 24–72 小時內侵入性策略（PCI）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>&gt;140</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>高風險</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>院內死亡率 &gt;3%</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.4319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:11.0pt;
  color:black'>緊急侵入性策略（PCI within 2h）</p>
  </td>
 </tr>
</table>

</div>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:16.0pt;color:black'>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt;color:black'>不穩定型心絞痛及NSTEMI治療</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:#2E75B5' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>主要治療目標：穩定病況、減少再梗塞</span></li>
 </ul>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>UA/NSTEMI：冠狀動脈「不完全阻塞」，仍有部分血流供應心肌，因此</span><span
      style='font-family:"Microsoft JhengHei";font-size:14.0pt;color:#2E75B5'>不需要緊急血栓溶解（Thrombolysis）。</span></li>
 </ul>
</ul>

<p style='margin-left:.375in;margin-top:5pt;margin-bottom:5pt;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt;color:black'>初期藥物治療（Antithrombotic
     &amp; Anti-ischemic Therapy）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
      style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:14.0pt;
      color:#70AD47'>抗血小板藥物（Antiplatelet Agents）</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-weight:bold;font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:#70AD47'>Aspirin（ASA）</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>：永久性抑制
       COX-1，減少 Thromboxane A2生成，防止血小板聚集</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-weight:bold;font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:#70AD47'>P2Y12 受體拮抗劑（Clopidogrel / Prasugrel /
       Ticagrelor）</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>可與
        Aspirin 合併使用（</span><span style='font-weight:bold;font-family:"Microsoft JhengHei";
        font-size:11.0pt;color:#70AD47'>Dual Antiplatelet Therapy, DAPT</span><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>Ticagrelor
        作用最強（但增加出血風險）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>Prasugrel
        禁用於中風病史患者</span></li>
   </ul>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
      style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:14.0pt;
      color:#70AD47'>抗凝血藥物（Anticoagulants）</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-weight:bold;font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:#70AD47'>Heparin（UFH 或 LMWH）</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>減少新血栓形成，預防進一步阻塞</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>UFH（未分化肝素）
        需持續監測 aPTT</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>LMWH（低分子量肝素，如
        Enoxaparin）：較穩定、不需監測 aPTT，臨床更常用</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-weight:bold;font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:#70AD47'>Bivalirudin（直接凝血酶抑制劑）</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>，如對
       Heparin 過敏可考慮</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
      style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:14.0pt;
      color:#70AD47'>抗缺血藥物（Anti-ischemic Therapy）</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:11.0pt;
       color:#70AD47'>Beta-blockers</span><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:black'>（β 阻斷劑）</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>減少心肌氧氣消耗（降低
        HR、BP、心肌收縮力）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>禁忌症：心因性休克、嚴重支氣管痙攣（如
        COPD, Asthma）</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:11.0pt;
       color:#70AD47'>Nitrates</span><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:black'>（如 Nitroglycerin）</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>緩解心絞痛，改善冠狀動脈血流</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>禁忌症：嚴重低血壓、右心梗塞（RV
        infarction）</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:11.0pt;
       color:#70AD47'>Statins</span><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:black'>（高劑量，如 Atorvastatin 80mg）</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>穩定動脈粥狀斑塊，減少心血管事件</span></li>
   </ul>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:1.5in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt;color:black'>介入治療（非緊急性心導管術
     /PCI）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-weight:bold;
      font-family:"Microsoft JhengHei";font-size:14.0pt;color:#70AD47'>NSTEMI
      不需要緊急PCI</span><span style='font-family:"Microsoft JhengHei";font-size:
      14.0pt;color:black'>，但</span><span style='font-weight:bold;font-family:
      "Microsoft JhengHei";font-size:14.0pt;color:#70AD47'>高風險患者仍應該考慮早期介入治療。</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>適用族群：高危險族群</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>GRACE
        score高（預測6個月內死亡風險）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>反覆胸痛
        / 血流動力學不穩</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>明顯
        ST-T 變化或生物標誌物升高（如 Troponin）</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>方法</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-weight:bold;font-family:"Microsoft JhengHei";
        font-size:11.0pt;color:#70AD47'>冠狀動脈造影（Coronary
        Angiography），依狀況決定是否放置支架（PCI）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-weight:bold;font-family:"Microsoft JhengHei";
        font-size:11.0pt;color:#70AD47'>必要時行冠狀動脈繞道手術（CABG）</span></li>
   </ul>
  </ul>
 </ul>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>風險分層</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.2284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>治療策略</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高風險（GRACE &gt;140）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.2284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>緊急 PCI（2 小時內）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>中風險（GRACE 109-140）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.209in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>24-72
  小時內 PCI</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>低風險（GRACE &lt;109）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.2284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>藥物治療（DAPT、抗凝、Statins）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>藥物治療</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.2979in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Aspirin
  + P2Y12 抑制劑 + Heparin（UFH/LMWH）</p>
  </td>
 </tr>
</table>

</div>

<p style='margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.0pt;
color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#1E4E79'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>ST段抬高型心肌梗塞（STEMI）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>機轉：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt;
       color:#C00000'>完全血管阻塞（100%），導致心肌急性缺血</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt;
       color:#C00000'>影響全層心肌（Transmural Infarction）</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>臨床表現：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt;
       color:#C00000'>劇烈胸痛（可能持續 &gt;30分鐘）</span><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:black'>，可能放射至左臂、下顎、頸部</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>可能伴有呼吸困難、盜汗、嘔吐</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt;
       color:#C00000'>無法被休息或舌下含服 NTG 緩解</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt;
       color:black'>ECG：</span><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:#C00000'>ST 段elevation</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>，可能合併新發左束支傳導阻滯（LBBB）</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>診斷關鍵：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>心肌酵素明顯上升</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>（Troponin
       I/T、CK-MB ↑）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'
       lang=en-US>ECG：ST 段抬高</span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:black' lang=en-US>≥</span><span style='font-family:
       "Microsoft JhengHei";font-size:11.0pt;color:black' lang=en-US>1
       mm（連續兩個肢體導聯）或 </span><span style='font-family:"Microsoft JhengHei Light";
       font-size:11.0pt;color:black' lang="x-IV_mathan">≥</span><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'
       lang=en-US>2 mm（連續胸導聯）</span></li>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
     lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:16.0pt'>STEMI
     ECG變化：</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:14.0pt;
      color:#C00000'>至少2個連續導程ST段抬高</span><span style='font-family:"Microsoft JhengHei";
      font-size:14.0pt;color:black'>，定義如下：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>V2-V3：</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt' lang=en-US>男性
        &lt;40 歲：</span><span style='font-family:"Microsoft JhengHei Light";
        font-size:11.0pt' lang="x-IV_mathan">≥</span><span style='font-family:
        "Microsoft JhengHei";font-size:11.0pt' lang=en-US>2.5 mm</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt' lang=en-US>男性
        </span><span style='font-family:"Microsoft JhengHei Light";font-size:
        11.0pt' lang="x-IV_mathan">≥</span><span style='font-family:"Microsoft JhengHei";
        font-size:11.0pt' lang=en-US>40 歲：</span><span style='font-family:"Microsoft JhengHei Light";
        font-size:11.0pt' lang="x-IV_mathan">≥</span><span style='font-family:
        "Microsoft JhengHei";font-size:11.0pt' lang=en-US>2.0 mm</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt' lang=en-US>女性：</span><span
        style='font-family:"Microsoft JhengHei Light";font-size:11.0pt'
        lang="x-IV_mathan">≥</span><span style='font-family:"Microsoft JhengHei";
        font-size:11.0pt' lang=en-US>1.5 mm</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt' lang=en-US>其他導程：</span><span
       style='font-family:"Microsoft JhengHei Light";font-size:11.0pt'
       lang="x-IV_mathan">≥</span><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt' lang=en-US>1 mm</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:14.0pt'>新發左束支傳導阻滯（LBBB），合併缺血症狀時，亦視為
      STEMI</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:14.0pt'>病程發展：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>超急性期（數分鐘內）：高聳T波（Hyperacute
       T waves）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>急性期（數小時內）：ST段抬高（ST
       elevation）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>數天內：病理性Q波（Pathologic
       Q wave）、T 波倒置</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>數週至數月：ST段恢復基線，T波持續倒置，病理性
       Q 波可永久存在</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>如果
       ST段在STEMI發作後2週仍未恢復至基線，可能暗示心室瘤（Ventricular Aneurysm）
       形成。這是一種慢性併發症，通常發生於前壁心肌梗塞（Anterior MI, LAD
       供應區域），因為該區心肌壞死後變成纖維化瘢痕（Scar），導致局部心室壁失去收縮能力（Akinetic
       zone），甚至在心臟收縮時呈現反向突出（Dyskinesia）</span></li>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#1E4E79'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>Cardiac
     biomarker重點：</span></li>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>生物標記</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>升高時間</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>高峰時間</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>持續時間</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>適用情境</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:#C00000'>Troponin I/T</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>2-4 小時</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>24-48 小時</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>7-14 天</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt'><span
  style='color:#C00000'>最敏感</span><span style='color:black'>、特異的 MI 標記，但</span><span
  style='color:#C00000'>不適合偵測再梗塞</span></p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:#C00000'>CK-MB</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>4-6 小時</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8201in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>24 小時</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>2-3 天</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt'><span
  style='color:black'>適合</span><span style='color:#C00000'>偵測再梗塞</span></p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:#C00000'>Myoglobin</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>1-2 小時</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8201in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>6-12 小時</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>24 小時</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>最快升高，但特異性低</p>
  </td>
 </tr>
</table>

</div>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt;color:black' lang=en-US><span style='font-family:"Microsoft JhengHei";
     font-size:16.0pt'>重點整理：</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>目前臨床上主要使用Troponin（I或T）來診斷急性心肌梗塞</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>CK-MB 則可輔助偵測再梗塞</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>Myoglobin特異性低（骨骼肌損傷也會影響）臨床上較少單獨使用</span></li>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>冠狀動脈解剖</span></li>
</ul>

<p style='margin:0in;margin-left:.375in'><img
src="d5b9d80542894bd78f7413552681baea_asset_0.png" width=362 height=232
alt="File:Coronary vessels, with annotated arteries.svg"></p>

<p style='margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>

<ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style='font-family:"Microsoft JhengHei";font-size:14.0pt'>主要血管分佈</span></li>
 <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:11.0pt'>左心冠狀動脈（Left Coronary Artery, LCA）</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>Left
      Main（LM） → 分出兩條：</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>LAD（Left
       Anterior Descending）</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>沿 interventricular plane（前降支）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>分支：</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>Septal Branch（S）：供應心室中隔</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>Diagonal Branch（D）：供應左心室前壁</span></li>
    </ul>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>LCX（Left
       Circumflex）</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>繞左心側壁（迴旋支）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>分支：</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>Obtuse Marginal（OM）：供應左心室側壁</span></li>
    </ul>
   </ul>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>右心冠狀動脈（Right
      Coronary Artery, RCA）</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>主要分支：</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>Conus Branch（CB）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>Sinus Node Branch（SN） → 供應 SA node</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>Right Ventricular Branch（RV）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>Acute Marginal（AcM） → 供應右心室</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>Posterolateral（PL） → 供應左心室後壁</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>Posterior Descending（PD） → 供應左心室下壁、後壁</span></li>
   </ul>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#1E4E79'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>STEMI 缺血區域對應 ECG
     變化</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>ST
      段抬高（STE）可用來定位缺血區域，但ST段壓低（STD）無法確定確切缺血位置</span></li>
 </ul>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>缺血區域</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>供應血管</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8006in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>ECG 導極變化（STE）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Septum（中隔）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>LAD</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.752in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>V1、V2</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>LV Anterior wall（前壁）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>LAD</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.752in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>V3、V4</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>LV Lateral wall（側壁）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>LCX 或 LAD 遠端</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.752in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>V5、V6、I、aVL</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>LV Inferior wall（下壁）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>RCA（較常見）或 LCX</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7326in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>II、III、aVF</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>LV Posterior wall（後壁）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>RCA 或 LCX</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.884in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>V1、V2（Tall R or STD）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>RV（右心室）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>RCA 近端</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.7569in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>V4R（右側導極）</p>
  </td>
 </tr>
</table>

</div>

<p style='margin-left:.375in;margin-top:5pt;margin-bottom:5pt;font-family:Calibri;
font-size:11.0pt'>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>下壁STEMI
     進一步分析（國考常考）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>下壁 STEMI（II、III、aVF STE）常見於 RCA
      阻塞，但 LCX 也可能導致！如何鑑別？</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>觀察
       lead II vs. lead III 的 STE</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>Lead III STE &gt; Lead II → RCA 阻塞</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>Lead II STE &gt; Lead III，且側壁（I、aVL）也有 STE → LCX 阻塞</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>右心室受累（RV
       infarction）</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>V4R STE → RCA 近端阻塞</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>臨床意義：</span></li>
    <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>右心梗塞不可使用 Nitrate（NTG）！</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>需補充體液（Hydration） 以維持前負荷</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>約 30% 下壁 STEMI 會合併右心梗塞</span></li>
    </ul>
   </ul>
  </ul>
 </ul>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>後壁
     STEMI（Posterior MI）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>ECG 變化</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
       5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
       "Microsoft JhengHei";font-size:11.0pt'>V1、V2 Tall R 波（對應後壁的 Q 波）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>V1、V2
       ST 段壓低（STD）（對應後壁的 STE）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>可合併下壁或側壁
       STEMI</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>V7–V9（後側導極）
       STE 可確診</span></li>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:.75in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#1E4E79'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>STEMI急性治療（國考考點）</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>治療目標： 立即恢復心肌灌流（Time is muscle!）</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
       5pt;margin-bottom:5pt;color:black'><span style='font-family:"Microsoft JhengHei";
       font-size:11.0pt;color:#C00000'>Primary PCI（首選！）</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
        5pt;margin-bottom:5pt;color:black'><span style='font-family:"Microsoft JhengHei";
        font-size:11.0pt;color:black' lang=en-US>目標：</span><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'
        lang=en-US>Door-to-Balloon </span><span style='font-family:"Cambria Math";
        font-size:11.0pt;color:#C00000' lang="x-IV_mathan">≤</span><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'
        lang=en-US> 90 分鐘</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>「Primary」指的是未先給血栓溶解劑，直接進行 PCI（經皮冠狀動脈介入治療）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>比血栓溶解劑更能降低死亡率、再梗塞風險</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>若能在 120 分鐘內完成 PCI，優先選擇！</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
        5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
        "Microsoft JhengHei";font-size:11.0pt'>適用對象</span></li>
    <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>症狀超過3小時</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>Killip class </span><span style='font-family:"Microsoft JhengHei Light";
         font-size:11.0pt'>≥</span><span style='font-family:"Microsoft JhengHei";
         font-size:11.0pt'> III（心衰、休克）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>有血栓溶解劑的禁忌症</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>高出血風險</span></li>
    </ul>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>Thrombolytic
       Therapy（血栓溶解劑）</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
        5pt;margin-bottom:5pt;color:black'><span style='font-family:"Microsoft JhengHei";
        font-size:11.0pt;color:black' lang=en-US>目標：</span><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'
        lang=en-US>Door-to-Needle </span><span style='font-family:"Cambria Math";
        font-size:11.0pt;color:#C00000' lang="x-IV_mathan">≤</span><span
        style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'
        lang=en-US> 30 分鐘</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>適用於 無法在 120 分鐘內完成 PCI 的醫院</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
        11.0pt'>施打後仍須立即轉診至可做 PCI 的醫院</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
        5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
        "Microsoft JhengHei";font-size:11.0pt'>適用對象</span></li>
    <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>症狀發作 &lt; 12 小時，超過 3小時效果下降</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>無禁忌症</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:
         11.0pt'>無法在 120 分鐘內完成 PCI</span></li>
    </ul>
   </ul>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#1E4E79'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>再灌流策略（PCI vs.
     溶栓）</span></li>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2451in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>治療</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>適應症</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>時間限制</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.275in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>備註</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2451in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Primary PCI（首選）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>具 STEMI 診斷，且可在 120 分鐘內完成 PCI</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Door-to-balloon time ≤90 分鐘</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>最佳療法，較少出血風險</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2451in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Fibrinolysis（溶栓治療）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>無法在 120 分鐘內完成 PCI</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Door-to-needle time ≤30 分鐘</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>適用於無法立即進行 PCI 的情況</p>
  </td>
 </tr>
</table>

</div>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:16.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
     lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:16.0pt'>根據衛福部
     STEMI 治療指引與臨床實務，以下是常見的醫院內部處置時間（Door-to-Reperfusion Time） 目標</span></li>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>步驟</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>時間目標</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>到院後 10 分鐘內（Door-to-ECG）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>完成 12 導程 ECG，確認 STEMI 診斷</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>到院後 30 分鐘內（Door-to-Needle）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>若適用 tPA（血栓溶解劑），應完成投藥</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>到院後 90 分鐘內（Door-to-Balloon）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8097in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>若適用 Primary PCI，應完成 氣球擴張</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>轉院病人（Door-to-Balloon）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>需在 120 分鐘內完成 PCI</p>
  </td>
 </tr>
</table>

</div>

<ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
     lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:14.0pt'>常見溶栓藥物：</span></li>
 <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>tPA（Alteplase）、Reteplase（rPA）、Tenecteplase（TNK-tPA）</span></li>
 </ul>
</ul>

<ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#2E75B5'
     lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:14.0pt'>禁忌症（國考愛考）</span></li>
 <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>近期出血性中風</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>活動性內出血（如消化道出血）</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>未控制的高血壓（SBP
      &gt;180 mmHg）</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>主動脈剝離疑慮</span></li>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#1E4E79'><span
     style='font-family:"Microsoft JhengHei";font-size:16.0pt'>急性期藥物治療（MONA-B）</span></li>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>縮寫</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.2187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>藥物</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.85in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>作用</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>M</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.2187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Morphine</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>緩解疼痛，減少交感興奮</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>O</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.2187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Oxygen</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.8222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>僅限於血氧 &lt;90%</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>N</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.2187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Nitroglycerin（NTG）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.85in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>緩解心絞痛，但不可用於右心室梗塞</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>A</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.225in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Aspirin（300 mg） + P2Y12 受體拮抗劑</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.85in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>DAPT（雙重抗血小板治療），如 Clopidogrel、Ticagrelor</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>B</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.2187in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Beta-blocker</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:2.85in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>減少心肌氧耗，避免再發生心律不整</p>
  </td>
 </tr>
</table>

</div>

<p style='margin-left:.375in;margin-top:5pt;margin-bottom:5pt;font-family:"Microsoft JhengHei";
font-size:16.0pt;color:black'>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt;color:black'><span style='font-family:"Microsoft JhengHei";
     font-size:16.0pt'>住院與長期治療</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
      lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:14.0pt'>藥物治療</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>DAPT（雙重抗血小板治療）：Aspirin
       + P2Y12 抑制劑（至少 12 個月）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>Statin（高強度）：Atorvastatin
       40-80 mg / Rosuvastatin 20-40 mg</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>ACEI
       / ARB：減少心臟重塑，預防心衰</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>Beta-blocker：降低猝死風險</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>Aldosterone
       antagonist（Spironolactone）：LVEF &lt;40% 或合併心衰患者</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:
      5pt;margin-bottom:5pt;color:black' lang=en-US><span style='font-family:
      "Microsoft JhengHei";font-size:14.0pt'>生活習慣調整</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>戒菸（Smoking
       cessation）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>控制三高（高血壓、糖尿病、高血脂）</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:11.0pt'>規律運動（適量有氧運動）</span></li>
  </ul>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>特徵</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>UA（不穩定型心絞痛）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>NSTEMI（非ST段抬高型心肌梗塞）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>STEMI（ST段抬高型心肌梗塞）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>血管阻塞程度</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>部分阻塞</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>部分阻塞</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>完全阻塞（100%）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>症狀</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>胸痛&lt;30 min</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>胸痛&lt;30 min</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>胸痛&gt;30 min</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>心肌壞死</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>無</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>有</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>有（更嚴重）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>心肌酵素</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>正常</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>上升</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.2694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>上升</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>ECG 變化</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.8902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>可能正常 / ST段depression / T波inversion</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.6715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>ST段depression/ T波inversion</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.4194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>ST 段elevation（2 個相鄰導程）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>主要治療</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.9097in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抗血小板、抗凝、硝酸鹽</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抗血小板、抗凝、β 阻斷劑</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.3812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>急診再灌注治療（PCI / tPA）</p>
  </td>
 </tr>
</table>

</div>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt' lang=en-US><span style='font-family:"Microsoft JhengHei";
     font-size:16.0pt;color:black'>記憶要點</span></li>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
      style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>UA
      與 NSTEMI 最大區別：心肌酵素是否上升（NSTEMI↑，UA 正常）</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
      style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>NSTEMI
      與 STEMI 最大區別：ECG 是否 ST 段抬高（STEMI 有，NSTEMI 無）</span></li>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
      style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>STEMI
      必須緊急再灌注治療（PCI 或溶栓 tPA）</span></li>
 </ul>
</ul>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
 margin-bottom:0in'>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
     lang=en-US><span style='font-family:"Microsoft JhengHei";font-size:16.0pt'>ACS藥物整理</span></li>
</ul>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt;margin-left:.3333in' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.768in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>藥物類別</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>代表藥物</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.102in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>作用機制</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>臨床作用</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>副作用</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black;text-align:center'>注意事項</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抗血小板藥物</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Aspirin</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抑制COX-1，降低 TXA2 生成</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>減少血小板聚集，預防血栓形成</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>胃潰瘍、出血風險、氣喘（AERD）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>長期使用需注意消化道潰瘍，可與 PPI 併用</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>P2Y12 抑制劑</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>阻斷ADP受體（P2Y12），抑制血小板聚集</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>與 Aspirin 併用（DAPT），預防支架血栓</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>出血、血小板減少症</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>選擇藥物依患者特徵</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>P2Y12 抑制劑</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Clopidogrel</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.102in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>不可逆抑制 P2Y12</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>需肝臟 CYP2C19 代謝，藥效延遲</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>CYP2C19 poor metabolizer 反應較差</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.993in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>基因多型性影響藥效，CYP2C19 poor metabolizer 避免使用</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>P2Y12 抑制劑</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Prasugrel</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>不可逆抑制 P2Y12，作用強於 Clopidogrel</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>較 Clopidogrel 更快、更強，但出血風險高</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>出血風險較高</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9819in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>75 歲以上、低體重（&lt;60 kg）、卒中病史禁用</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>P2Y12 抑制劑</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Ticagrelor</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>可逆抑制P2Y12，非前驅藥（直接作用）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>較 Clopidogrel 更快、更強，不受 CYP2C19 影響</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>呼吸困難（Dyspnea）、高尿酸血症、出血風險</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>需 BID 服用，依從性較差</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抗凝劑</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>UFH</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>透過 Antithrombin III 抑制Factor IIa（Thrombin）&amp; Xa</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>速效，PCI 前常用</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>出血、HIT</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>需監測 aPTT，HIT 風險高時避免使用</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=en-US>抗凝劑</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Enoxaparin（LMWH）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>主要抑制 Factor Xa，部分抑制 Thrombin（IIa）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>半衰期較 UFH 長，皮下注射給藥</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>出血、腎功能不佳者需調整劑量</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.993in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>肌酐清除率（CrCl）&lt;30 mL/min 時調整劑量</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black' lang=en-US>抗凝劑</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Bivalirudin</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>直接抑制 Thrombin（IIa），不經過 Antithrombin</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>可替代 Heparin，降低出血風險</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>出血、腎功能不佳者需調整劑量</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.8979in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>常用於 HIT 風險高者</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>血管擴張劑</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Nitroglycerin（NTG）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>轉換為NO，活化 cGMP，血管擴張</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>緩解心絞痛、降低心肌耗氧量</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>頭痛、低血壓、反射性心動過速</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.993in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>禁忌：使用 PDE5 抑制劑者（如 Sildenafil）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>β 阻斷劑</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Metoprolol（選擇性 β1 阻斷劑）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抑制β1受體，減少心肌收縮力與心率</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>降低心肌氧需求，減少猝死風險</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>禁忌：心源性休克、急性心衰竭、嚴重支氣管痙攣</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>合併低血壓或心動過緩者應避免使用</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>ACEI</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Enalapril, Ramipril</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抑制ACE，降低 Angiotensin II 生成</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>降低血壓、減少心臟重塑，適用於 LVEF &lt;40% 或糖尿病患者</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>乾咳（ACEI 特有）、高血鉀、低血壓、腎功能惡化</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>腎動脈狹窄患者禁用</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>ARB</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Losartan, Valsartan</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1076in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>阻斷Angiotensin II AT1 受體</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>作用類似 ACEI，但無乾咳副作用</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高血鉀、低血壓、腎功能惡化</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>腎功能不佳患者需監測血鉀</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Statin（HMG-CoA 還原酶抑制劑）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Atorvastatin 40–80 mg</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>抑制HMG-CoA 還原酶，減少肝臟膽固醇合成，增加 LDL 受體表達</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>顯著降低 LDL-C，穩定斑塊，抗發炎</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>肝酵素上升、肌肉痠痛（myopathy）、橫紋肌溶解（罕見）</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.993in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>需監測肝功能及 CK（若有肌肉症狀）</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Statin</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>Rosuvastatin 20–40 mg</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.1125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>效力更強的 Statin，類似 Atorvastatin</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>高強度降脂，適用於 ACS 患者</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:1.0777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>腎功能不佳者須調整劑量，類似 Atorvastatin副作用</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
  color:black'>CrCl &lt;30 mL/min 時，建議減量</p>
  </td>
 </tr>
</table>

</div>

<p style='margin:0in;margin-left:.375in;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>&nbsp;</p>

<p style='margin-left:.375in;margin-top:5pt;margin-bottom:5pt;font-family:"Microsoft JhengHei";
font-size:11.0pt;color:black' lang=en-US>REFERENCE：</p>

<ol type=1 style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
 0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:normal'>
 <li value=1 style='margin-top:0;margin-bottom:0;vertical-align:middle;
     margin-top:5pt;margin-bottom:5pt' lang=en-US><span style='font-family:
     Calibri;font-size:11.0pt;font-weight:normal;font-style:normal;font-family:
     Calibri;font-size:11.0pt'>HARRISON Principles of Internal Medicine 20th
     Edition</span></li>
</ol>

<ol type=1 style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
 0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:normal'>
 <li value=2 style='margin-top:0;margin-bottom:0;vertical-align:middle'
     lang=en-US><span style='font-family:Calibri;font-size:11.0pt;font-weight:
     normal;font-style:normal;font-family:Calibri;font-size:11.0pt'>Boards
     &amp; Beyonds</span><span style='font-family:"Microsoft JhengHei";
     font-size:11.0pt;font-weight:normal;font-style:normal;font-family:"Microsoft JhengHei";
     font-size:11.0pt'>：</span><span style='font-family:Calibri;font-size:11.0pt;
     font-weight:normal;font-style:normal;font-family:Calibri;font-size:11.0pt'>STEMI</span></li>
</ol>

<ol type=1 style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
 0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:normal'>
 <li value=3 style='margin-top:0;margin-bottom:0;vertical-align:middle;
     margin-top:5pt;margin-bottom:5pt'><a
     href="https://www.tsoc.org.tw/upload/files/acs-39-004-1(1).pdf"><span
     style='font-family:"Microsoft JhengHei";font-size:11.0pt;font-family:"Microsoft JhengHei";
     font-size:11.0pt' lang=en-US>https://www.tsoc.org.tw/upload/files/acs-39-004-1(1).pdf</span></a></li>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt'><a
     href="https://www.tsoc.org.tw/upload/files/2018%20Guidelines%20of%20TSOC_EM%20and%20TSCI%20for%20the%20management%20of%20non%20ST-segment%20elevation%20acute%20coronary%20syndrome(1).pdf"><span
     style='font-family:"Microsoft JhengHei";font-size:11.0pt' lang=en-US>https://www.tsoc.org.tw/upload/files/2018%20Guidelines%20of%20TSOC_EM%20and%20TSCI%20for%20the%20management%20of%20non%20ST-segment%20elevation%20acute%20coronary%20syndrome(1).pdf</span></a></li>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt'><a
     href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309"><span
     style='font-family:"Microsoft JhengHei";font-size:11.0pt' lang=en-US>https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309</span></a></li>
 <li style='margin-top:0;margin-bottom:0;vertical-align:middle;margin-top:5pt;
     margin-bottom:5pt'><a
     href="https://commons.wikimedia.org/wiki/File:Coronary_vessels,_with_annotated_arteries.svg"><span
     style='font-family:Calibri;font-size:11.0pt'>https://commons.wikimedia.org/wiki/File:Coronary_vessels,_with_annotated_arteries.svg</span></a></li>
</ol>

<p style='margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.0pt'
lang=en-US>&nbsp;</p>

</div>

</div>

</div>

<div>

<p style='margin:0in'>&nbsp;</p>

<p style='text-align:left;margin:0in;font-family:Arial;font-size:9pt;
color:#969696;direction:ltr'>使用 OneNote 建立。</p>

</div>

</body>

</html>